tradingkey.logo

Advanced Biomed Inc

ADVB
0.284USD
-0.018-6.00%
收盤 02/02, 16:00美東報價延遲15分鐘
6.14M總市值
虧損本益比TTM

Advanced Biomed Inc

0.284
-0.018-6.00%

關於 Advanced Biomed Inc 公司

Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Advanced Biomed Inc簡介

公司代碼ADVB
公司名稱Advanced Biomed Inc
上市日期Mar 06, 2025
CEO- -
員工數量31
證券類型Ordinary Share
年結日Mar 06
公司地址401 Ryland St
城市RENO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編89502
電話1862120510823
網址http://www.advanbiomed.com/
公司代碼ADVB
上市日期Mar 06, 2025
CEO- -

Advanced Biomed Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 2月1日 週日
更新時間: 2月1日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Lu (Yi Ph.D.)
31.00%
Pau (Hung To)
16.29%
Advance on Ventures Ltd
10.09%
Luo (Xiaoyuan)
6.46%
Zhu (Beili)
5.59%
其他
30.58%
持股股東
持股股東
佔比
Lu (Yi Ph.D.)
31.00%
Pau (Hung To)
16.29%
Advance on Ventures Ltd
10.09%
Luo (Xiaoyuan)
6.46%
Zhu (Beili)
5.59%
其他
30.58%
股東類型
持股股東
佔比
Individual Investor
59.33%
Corporation
10.09%
Hedge Fund
0.64%
Venture Capital
0.24%
Investment Advisor
0.18%
Research Firm
0.15%
其他
29.36%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
6
262.83K
0.61%
--
2025Q3
6
262.83K
0.61%
+131.46K
2025Q2
4
131.38K
0.05%
+120.16K
2025Q1
1
11.21K
0.00%
+11.21K

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Lu (Yi Ph.D.)
6.71M
31%
--
--
Jul 23, 2025
Pau (Hung To)
3.52M
16.29%
--
--
Jul 23, 2025
Advance on Ventures Ltd
2.18M
10.09%
--
--
Jul 23, 2025
Luo (Xiaoyuan)
1.40M
6.46%
--
--
Jul 23, 2025
Citadel Advisors LLC
139.51K
0.64%
+81.84K
+141.92%
Sep 30, 2025
XTX Markets LLC
52.23K
0.24%
+52.23K
--
Sep 30, 2025
HRT Financial LP
35.68K
0.16%
+35.68K
--
Sep 30, 2025
Virtu Americas LLC
32.05K
0.15%
+7.77K
+32.00%
Sep 30, 2025
UBS Financial Services, Inc.
3.36K
0.02%
-21.47K
-86.47%
Sep 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI